1. In vitro and histological investigation of antitumor effect of some triazole compounds in colon cancer cell line
- Author
-
Pelin Koparir, Ali Osman Çeribaşi, Hafize Telceken, Mustafa Karatepe, Suat Tekin, Akif Evren Parlak, and Arzu Karatepe
- Subjects
0301 basic medicine ,Antioxidant ,Azoxymethane ,Colorectal cancer ,medicine.medical_treatment ,Cell Biology ,Pharmacology ,Antimicrobial ,medicine.disease ,Biochemistry ,In vitro ,03 medical and health sciences ,chemistry.chemical_compound ,030104 developmental biology ,0302 clinical medicine ,chemistry ,In vivo ,030220 oncology & carcinogenesis ,otorhinolaryngologic diseases ,medicine ,Adenocarcinoma ,Viability assay ,Molecular Biology - Abstract
1,2,4-Triazoles are used as antifungal, antibacterial, antimicrobial, and antioxidant against some oxidative radical species. Recently, many 1,2,4-triazoles continue to be synthesized. In this study, the effect of the 1,2,4-triazole derivatives on human colon cancer (HT29) was investigated in vitro and in vivo in rats. MTT test was applied to in in vitro experiments. For in vivo study, rats were divided into seven groups as follows: Control group (negative control), azoxymethane (AOM), AOM + cisplatin 15, AOM + L1, AOM + L2, AOM + L3, and AOM + L4. To create colon cancer, the AOM injection was injected subcutaneously at a dose of 15 mg/kg, three times (once weekly). The in vivo studies were completed at 28 weeks. It was found that the 1,2,4-triazole derivatives reduced the cell viability (P
- Published
- 2019
- Full Text
- View/download PDF